Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dalmi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Blut|May 1, 1984
Detection of platelet-associated IgG in chronic immune thrombocytopenic purpura using antibody-coated polyacrylamide beadsK Pecze, G Pfliegler, L Dalmi, et al.
Acta Physiologica Hungarica|January 1, 1992
The effect of silibinin (Legalon) on the the free radical scavenger mechanisms of human erythrocytes in vitroI Altorjay, L Dalmi, B Sári, et al.
Therapia Hungarica (English Edition)|January 1, 1984
Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseasesG Pfliegler, Z Boda, L Dalmi, et al.
Acta Medica Hungarica|January 1, 1991
Autoantibody against liver cell membrane and killer cell activity in chronic liver diseasesR Schnabel, L Dalmi, S Sipka, et al.
Orvosi Hetilap|November 10, 1996
[Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection]J Mátyus, J Kovács, L Ujhelyi, et al.
Orvosi Hetilap|December 20, 1970
[Studies of immunoglobulins in acute hepatitis]A Prékopa, L Dalmi, R Zayzon, et al.
Zentralblatt Fur Chirurgie|April 27, 1973
[Analysis of immunoglobulins in obstructive jaundice]L Dalmi, A Prekopa, F Boján, et al.
Scandinavian Journal of Gastroenterology|December 1, 2000
C5b-9 and interleukin-6 in chronic hepatitis C. Surrogate markers predicting short-term response to interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Orvosi Hetilap|June 2, 1996
[Effect of interferon-alpha2b therapy in chronic hepatitis C]J Fehér, G Lengyel, L Dalmi, et al.
Immunology Letters|June 8, 2000
Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Blut|May 1, 1984
Detection of platelet-associated IgG in chronic immune thrombocytopenic purpura using antibody-coated polyacrylamide beadsK Pecze, G Pfliegler, L Dalmi, et al.
Acta Physiologica Hungarica|January 1, 1992
The effect of silibinin (Legalon) on the the free radical scavenger mechanisms of human erythrocytes in vitroI Altorjay, L Dalmi, B Sári, et al.
Therapia Hungarica (English Edition)|January 1, 1984
Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseasesG Pfliegler, Z Boda, L Dalmi, et al.
Acta Medica Hungarica|January 1, 1991
Autoantibody against liver cell membrane and killer cell activity in chronic liver diseasesR Schnabel, L Dalmi, S Sipka, et al.
Orvosi Hetilap|November 10, 1996
[Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection]J Mátyus, J Kovács, L Ujhelyi, et al.
Orvosi Hetilap|December 20, 1970
[Studies of immunoglobulins in acute hepatitis]A Prékopa, L Dalmi, R Zayzon, et al.
Zentralblatt Fur Chirurgie|April 27, 1973
[Analysis of immunoglobulins in obstructive jaundice]L Dalmi, A Prekopa, F Boján, et al.
Scandinavian Journal of Gastroenterology|December 1, 2000
C5b-9 and interleukin-6 in chronic hepatitis C. Surrogate markers predicting short-term response to interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Orvosi Hetilap|June 2, 1996
[Effect of interferon-alpha2b therapy in chronic hepatitis C]J Fehér, G Lengyel, L Dalmi, et al.
Immunology Letters|June 8, 2000
Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Pageof 3